Population model‐based analysis of the memory B‐cell response following belimumab therapy in the treatment of systemic lupus erythematosus

por Dimelow, Richard, Gillespie, William R., van Maurik, Andre
Publicado 2023

10 Years of belimumab experience: What have we learnt?

por Levy, Roger A, Gonzalez-Rivera, Tania, Khamashta, Munther, Fox, Norma Lynn, Jones-Leone, Angela, Rubin, Bernie, Burriss, Susan W, Gairy, Kerry, van Maurik, Andre, Roth, David A
Publicado 2021

Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I...

por Hillen, Maarten R, Urso, Katia, Koppe, Emma, Lopes, Ana Pinheiro, Blokland, Sofie L M, Pandit, Aridaman, Slocombe, Tom, van Maurik, André, van Roon, Joel A G, Radstake, Timothy R D J
Publicado 2020

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes

por Keymeulen, Bart, van Maurik, André, Inman, Dave, Oliveira, João, McLaughlin, Rene, Gittelman, Rachel M., Roep, Bart O., Gillard, Pieter, Hilbrands, Robert, Gorus, Frans, Mathieu, Chantal, Van de Velde, Ursule, Wisniacki, Nicolas, Napolitano, Antonella
Publicado 2020

A randomised study of rituximab and belimumab sequential therapy in PR3 ANCA-associated vasculitis (COMBIVAS): design of the study protocol

por McClure, Mark E., Gopaluni, Seerapani, Wason, James, Henderson, Robert B., Van Maurik, Andre, Savage, Caroline C.O., Pusey, Charles D., Salama, Alan D., Lyons, Paul A., Lee, Jacinta, Mynard, Kim, Jayne, David R., Jones, Rachel B.
Publicado 2023

Epigenetically quantified immune cells in salivary glands of Sjögren’s syndrome patients: a novel tool that detects robust correlations of T follicular helper cells with immunopath...

por Blokland, Sofie L M, van Vliet-Moret, Fréderique M, Hillen, Maarten R, Pandit, Aridaman, Goldschmeding, Roel, Kruize, Aike A, Bouma, Gerben, van Maurik, André, Olek, Sven, Hoffmueller, Ulrich, van Roon, Joel A G, Radstake, Timothy R D J
Publicado 2020

A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome

por Mariette, Xavier, Barone, Francesca, Baldini, Chiara, Bootsma, Hendrika, Clark, Kenneth L., De Vita, Salvatore, Gardner, David H., Henderson, Robert B., Herdman, Michael, Lerang, Karoline, Mistry, Prafull, Punwaney, Raj, Seror, Raphaele, Stone, John, van Daele, Paul L.A., van Maurik, André, Wisniacki, Nicolas, Roth, David A., Tak, Paul Peter
Publicado 2022

Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren’s syndrome

por Jimenez-Royo, Pilar, Bombardieri, Michele, Ciurtin, Coziana, Kostapanos, Michalis, Tappuni, Anwar R, Jordan, Natasha, Saleem, Azeem, Fuller, Teresa, Port, Kathleen, Pontarini, Elena, Lucchesi, Davide, Janiczek, Robert, Galette, Paul, Searle, Graham, Patel, Neel, Kershaw, Lucy, Gray, Calum, Ratia, Nirav, van Maurik, André, de Groot, Marius, Wisniacki, Nicolas, Bergstrom, Mats, Tarzi, Ruth
Publicado 2020

Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects – a randomized, double‐blind, placebo‐controlled study

por Ellis, Joanne, van Maurik, Andre, Fortunato, Lea, Gisbert, Sophie, Chen, Keguan, Schwartz, Ann, McHugh, Simon, Want, Andrew, Santos Franco, Sara, Oliveira, Joao‐Joaquim, Price, Jeffrey, Coles, Alasdair, Brown, Kim, Su, Donggang, Craigen, Jenny L., Yang, Jiansong, Brett, Sara, Davis, Bill, Cheriyan, Joseph, Kousin‐Ezewu, Onajite, Gray, Frank, Thompson, Paul W., Fernando, Disala
Publicado 2018